PetIQ Inc (NASDAQ:PETQ) Given Consensus Recommendation of “Buy” by Analysts
Shares of PetIQ Inc (NASDAQ:PETQ) have been assigned a consensus recommendation of “Buy” from the nine analysts that are presently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $41.14.
Several brokerages have commented on PETQ. Guggenheim began coverage on PetIQ in a research note on Thursday, May 23rd. They set a “buy” rating and a $35.00 target price on the stock. Zacks Investment Research upgraded PetIQ from a “hold” rating to a “buy” rating and set a $36.00 target price on the stock in a research note on Friday, August 9th. ValuEngine downgraded PetIQ from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, BidaskClub downgraded PetIQ from a “buy” rating to a “hold” rating in a research note on Thursday.
In other news, insider Will Santana sold 10,000 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $31.68, for a total transaction of $316,800.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders have sold a total of 110,291 shares of company stock worth $3,436,491 over the last three months. Insiders own 23.79% of the company’s stock.
PETQ traded down $1.09 during trading on Friday, hitting $31.07. 11,740 shares of the company’s stock traded hands, compared to its average volume of 491,942. The business’s 50 day moving average is $34.12. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.89 and a quick ratio of 1.51. PetIQ has a 12-month low of $21.29 and a 12-month high of $43.93. The firm has a market cap of $906.91 million, a PE ratio of 24.98, a price-to-earnings-growth ratio of 1.26 and a beta of 2.06.
PetIQ (NASDAQ:PETQ) last issued its earnings results on Wednesday, August 7th. The company reported $0.70 EPS for the quarter, beating the consensus estimate of $0.35 by $0.35. PetIQ had a return on equity of 10.54% and a net margin of 0.68%. The business had revenue of $220.60 million for the quarter, compared to the consensus estimate of $193.89 million. During the same period last year, the business posted $0.66 EPS. The company’s revenue was up 28.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that PetIQ will post 1.07 earnings per share for the current fiscal year.
PetIQ Company Profile
PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.